Share Prices & Company Research

Market News

06 Sep 2023 | 13:24

Updated Covid vaccine effective against new strain - Moderna

(Sharecast News) - Moderna's updated Covid-19 vaccine has shown to be effective against a potentially dangerous new variant, the US biotech said on Wednesday. Moderna said clinical trial data had shown that its updated Covid vaccine - which is pending regulatory approval in the US for the coming autumn vaccination season - demonstrated an 8.7 to 11-fold increase in neutralising antibodies against circulating variants including BA.2.86.

There are concerns that the new, highly-mutated BA.2.86 variant could be more likely to cause infections, even in people who have already had Covid or are already vaccinated.

Stephen Hoge, Moderna president, said: "Taken together with our previously communicated results showing a similarly effective response against EG.5 and FL.1.5.1 variants, these data confirm that our updated Covid-19 vaccine will continue to be an important tool for protection as we head into the fall vaccination season."

Moderna said it had shared the clinical trial data with regulators as well as submitting it for peer review.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new portfolio or transferring your portfolio from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.